Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomised withdrawal study of long-term Sativex in MS spasticity
2007-002138-13Phase 3Completed
- Sponsor
- GW Pharmaceuticals
- Start
- Jun 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in multiple sclerosis (MS) and Muscle spasm comparing Continue Sativex with Switch to placebo (2 arms). Primary endpoint: Time to treatment failure. Started Jun 2007; status: completed.
02
Drugs
cannabidiol
03
Conditions
multiple sclerosis (MS)Muscle spasm
Beyond the preview
Go deeper on 2007-002138-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-002138-13.